PET with CTC detects polyps well, requires no cleansing

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 6
Volume 32
Issue 6

PET with CT colonography provides an alternative for detecting polyps and cancer in the colon, according to a study published in the Journal of Nuclear Medicine. PET with CT colonography (CTC) is especially helpful because it does not require bowel preparation.

The study, involving 56 patients, is the largest to date investigating PET CTC in patients without bowel preparation. The patients underwent a PET CTC two weeks before their scheduled colonoscopy, the standard diagnostic test for colorectal cancer.

CTC sensitivity for polyps 6 mm or larger was 92.9% and was not improved by the addition of PET. But by combining PET with CTC, per-patient positive predictive value for a polyp 10 mm or greater jumped from 73% to 100% (J Nucl Med 2010;51:854-861).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.